Page 36 - Molecular features of low-grade developmental brain tumours
P. 36
1
34
CHAPTER 1
220. Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469-474, doi:10.1038/nature26000 (2018).
221. Stone, T. J. et al. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours. Acta Neuropathol 135, 115-129, doi:10.1007/s00401-017-1773-z (2018).
222. Huse, J. T. et al. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133, 417-429, doi:10.1007/ s00401-016-1639-9 (2017).
223. Deng, M. Y. et al. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136, 239-253, doi:10.1007/s00401-018-1865-4 (2018).
224. Muhlebner, A., Bongaarts, A., Sarnat, H. B., Scholl, T. & Aronica, E. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives. J Anat 235, 521-542, doi:10.1111/joa.12956 (2019).
